Crispr Therapeutics's chart data is dated 2026-10-08. Recorded technical signals: Death cross. There are 6 published signal records.
Crispr Therapeutics last closed at $50.44 (-3.65%) on 2026-10-08. Signals today: Death cross. Listed on Nasdaq. Trailing 12 months PER is -10.8×. Its overall grade ranks 321 of 738 stocks in Healthcare.
About this company
Crispr Therapeutics last closed at $50.44 (-3.65%) on 2026-10-08. Signals today: Death cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 321/738
Valuation grade B+
Related stocks
- Vertex PharmaceuticalsCustomer
CRISPR 치료제 exa-cel의 상업화 파트너
- NovartisCustomer
초기 CRISPR/Cas9 치료제 공동개발 및 파트너십 이력
- Bristol Myers SquibbSupplier
CRISPR 기반 세포치료제 협업 파트너
ETFs holding this stock
ARK Genomic Revolution ETF · ARK Innovation ETF · AXS Green Alpha ETF
Details →About Crispr Therapeutics
- What technical signals does Crispr Therapeutics (CRSP) have?
- Crispr Therapeutics current technical signals: death cross (5_20, 0d ago).
- Is Crispr Therapeutics a cup-and-handle pattern?
- No. Crispr Therapeutics has no valid Cup signal right now.
- What published figures are available for Crispr Therapeutics?
- Market cap: $4.81B. Trailing 12 months PER: -10.8×. Latest quarter PBR: 2.79×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Crispr Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.